Is Crinetics Pharmaceuticals Inc (CRNX) a Smart Choice in Biotechnology Monday?

A rating of 95 puts Crinetics Pharmaceuticals Inc (CRNX) near the top of the Biotechnology industry according to InvestorsObserver. Crinetics Pharmaceuticals Inc's score of 95 means it scores higher than 95% of stocks in the industry. Crinetics Pharmaceuticals Inc also received an overall rating of 79, putting it above 79% of all stocks. Biotechnology is ranked 47 out of the 148 industries.

CRNX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on CRNX!

See Full CRNX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Crinetics Pharmaceuticals Inc Stock Today?

Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $30.27 as of 11:58 AM on Monday, Nov 20, a gain of $0.28, or 0.93% from the previous closing price of $29.99. The stock has traded between $29.23 and $31.23 so far today. Volume today is low. So far 148,447 shares have traded compared to average volume of 837,479 shares. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.